K279-1012 Screening compound: N~1~-CYCLOHEXYL-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

K279-1012 Screening compound: N~1~-CYCLOHEXYL-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE
K279-1012 Screening compound: N~1~-CYCLOHEXYL-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1012
N~1~-CYCLOHEXYL-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1012

Molecular Formula

C26H33N5O4S (C26 H33 N5 O4 S)

Compound Name

N~1~-CYCLOHEXYL-3-[2-OXO-5-({2-OXO-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]ETHYL}SULFANYL)-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

IUPAC name

n/a

SMILES

O=C(CCC1N2C(SCC(NCC3OCCC3)=O)=Nc(cccc3)c3C2=NC1=O)NC1CCCCC1

InChI

InChI=1S/C26H33N5O4S/c32-22(28-17-7-2-1-3-8-17)13-12-21-25(34)30-24-19-10-4-5-11-20(19)29-26(31(21)24)36-16-23(33)27-15-18-9-6-14-35-18/h4-5,10-11,17-18,21H,1-3,6-9,12-16H2,(H,27,33)(H,28,32)

InChI Key

YGCXOSHACBNSFP-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

511.65

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.549

Distribution Coefficient, logD

1.549

Water Solubility, LogSw

-2.56

Polar Surface Area

92.474

Acid Dissociation Constant (pKa)

10.29

Base Dissociation Constant (pKb)

3.90

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

57.70

K279-1012 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K279-1012 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1012?
Check Price and Availability of K279-1012, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1012 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1012
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1012
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1012 available by request